普米克令舒联合沐舒坦雾化吸入在肺部手术后的临床疗效分析  

The Clinical Analysis of Application of Auxiliary Spray Inhalation with Mucosolvan Combined with Pulmicort in After Lung Surgery

作　　者：黄小龙[1] 宋之昭[1] 吴西林[1] 

机构地区：[1]柳州医学高等专科学校第一附属医院心胸外科,广西柳州545002

出　　处：《中国医药指南》2014年第12期48-48,70,共2页Guide of China Medicine

摘　　要：目的观察沐舒坦联合普米克令舒雾化吸入在肺部手术后的临床疗效。方法将120例肺部手术后的患者随机分为沐舒坦联合普米克令舒氧气雾化吸入组(试验组)60例和对照组60例(超声雾化吸入法)进行研究。结果试验组在效果、血气分析的显著改变及肺功能的显著改变明显优于对照组(P<0.05),试验组总有效率为96.7%,对照组总有效率为79.8%,两组有显著性差异(P<0.05)。结论沐舒坦联合普米克令舒雾化吸入在肺部手术后疗效确切,值得临床推广。Objective To observe the clinical therapeutic effect of spray inhalation with mucosolvan and Pulmicort in After Lung Surgery. Methods 120 cases were divided into two groups, atomizing inhalation of Pulmicort and mucosolvan（n=60）and ultrasonic at-omizing inhalation （n=60）. Results such Efficacy and Blood gas analysis results in a significant and change Significant changes in lung function in treatmentgroup was superior to those of the control group significantly. The effect of treatment group was better than that of the controlgroup（P〈0.05）.There was staticaldifference between two groups（P〈0.05）.Conclusion Themethod of atomizing inhala-tion of Pulmicort andmucosolvan has an exact effecton After Lung Surgery and has a certain value for clinicalgeneral-ization.

关 键 词：沐舒坦 普米克令舒 雾化吸入 肺部手术 

分 类 号：R725.6[医药卫生—儿科]